Trial of SAVVY Vaginal Gel and HIV in Nigeria

Update Il y a 4 ans
Reference: NCT00130078

Woman Man

  • | Country :
  • Nigeria
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.


Inclusion criteria

  • HIV Infections

Links